Letter to the Editor
Triple Therapy in Idiopathic Pulmonary Fibrosis
Triple terapia en fibrosis pulmonar idiopática
Read
5129
Timeswas read the article
1860
Total PDF
3269
Total HTML
Share statistics
array:23 [ "pii" => "S1579212914001220" "issn" => "15792129" "doi" => "10.1016/j.arbr.2013.08.010" "estado" => "S300" "fechaPublicacion" => "2014-06-01" "aid" => "827" "copyright" => "SEPAR" "copyrightAnyo" => "2014" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2014;50:260-1" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2462 "formatos" => array:3 [ "EPUB" => 126 "HTML" => 1802 "PDF" => 534 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0300289613002731" "issn" => "03002896" "doi" => "10.1016/j.arbres.2013.08.004" "estado" => "S300" "fechaPublicacion" => "2014-06-01" "aid" => "827" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2014;50:260-1" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5285 "formatos" => array:3 [ "EPUB" => 128 "HTML" => 4543 "PDF" => 614 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>" "titulo" => "Triple terapia en fibrosis pulmonar idiopática" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "260" "paginaFinal" => "261" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Triple Therapy in Idiopathic Pulmonary Fibrosis" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Diego Castillo Villegas, Silvia Barril Farré" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Diego" "apellidos" => "Castillo Villegas" ] 1 => array:2 [ "nombre" => "Silvia" "apellidos" => "Barril Farré" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1579212914001220" "doi" => "10.1016/j.arbr.2013.08.010" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212914001220?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289613002731?idApp=UINPBA00003Z" "url" => "/03002896/0000005000000006/v1_201405240608/S0300289613002731/v1_201405240608/es/main.assets" ] ] "itemAnterior" => array:19 [ "pii" => "S1579212914001219" "issn" => "15792129" "doi" => "10.1016/j.arbr.2013.08.009" "estado" => "S300" "fechaPublicacion" => "2014-06-01" "aid" => "828" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2014;50:260" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2423 "formatos" => array:3 [ "EPUB" => 123 "HTML" => 1702 "PDF" => 598 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Quality Spirometry: What Do We Base Our Definition On?" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "260" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Calidad en la espirometría, ¿en qué nos basamos para definirla?" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jordi Giner Donaire" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Jordi" "apellidos" => "Giner Donaire" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0300289613002743" "doi" => "10.1016/j.arbres.2013.08.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289613002743?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212914001219?idApp=UINPBA00003Z" "url" => "/15792129/0000005000000006/v1_201405291004/S1579212914001219/v1_201405291004/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Triple Therapy in Idiopathic Pulmonary Fibrosis" "tieneTextoCompleto" => true "saludo" => "<span class="elsevierStyleItalic">To the Editor</span>:" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "260" "paginaFinal" => "261" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Diego Castillo Villegas, Silvia Barril Farré" "autores" => array:2 [ 0 => array:4 [ "nombre" => "Diego" "apellidos" => "Castillo Villegas" "email" => array:1 [ 0 => "d.castillo@rbht.nhs.uk" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Silvia" "apellidos" => "Barril Farré" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Royal Brompton Hospital, Londres, United Kingdom" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Neumología, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Triple terapia en fibrosis pulmonar idiopática" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">We have read with particular interest the new “Guidelines for the diagnosis and treatment of idiopathic pulmonary fibrosis (IPF)”.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> It is clear that, as in the previous guidelines published in 2003 (one of the most widely read articles of this journal), Xaubet et al. have made a brilliant summary of the most important aspects of this disease.</p><p id="par0010" class="elsevierStylePara elsevierViewall">One of the main novelties compared to the previous guidelines is regarding treatment. In the past 10 years there has been a shift in the treatment of the IPF patient from immunomodulators to the new antifibrotic drugs, and this is clearly reflected in the document. However, there is one clinical situation that has not been clarified: how should patients already diagnosed with IPF that are stable on triple therapy (N-acetylcysteine, low-dose prednisone and azathioprine) be managed? Certainly, many other clinicians like ourselves will have asked the same question when reading the guidelines. This is a problem that we would like to examine further.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Although the provisional results of the PANTHER study were widely received with alarm, as Wells et al. recently pointed out, this does not mean a permanent farewell to immunomodulators in IPF.<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2,3</span></a> It should be remembered that the IFIGENIA study data showed a reduction in disease progression in patients receiving triple therapy.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> Moreover, the adverse effects reported in the PANTHER study were associated with the use of high-dose steroids. For this reason, many experts believe that it is reasonable to maintain triple therapy with low-dose steroids in patients who have remained stable on this regimen.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Accordingly, each case can be evaluated by following three simple steps:<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">1.</span><p id="par0025" class="elsevierStylePara elsevierViewall">IPF diagnosis: this is another great step forward reflected in the guidelines. Diagnostic criteria are becoming ever more specific. And we know that patients with an incorrect diagnosis of IPF tend to respond better to immunosuppressive treatment, particularly those with non-specific interstitial pneumonia. Thus, the first step consists of reviewing the clinical records to confirm that the patient meets the diagnostic criteria specified in the new guidelines.</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">2.</span><p id="par0030" class="elsevierStylePara elsevierViewall">Clinical stability: patients often continue to receive a certain treatment indefinitely, despite complete lack of response. For this reason, the next step would be to review clinical, radiological and functional parameters to ensure that the patient does not present significant deterioration.</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">3.</span><p id="par0035" class="elsevierStylePara elsevierViewall">Tolerance and complications from immunosuppressive treatment: the final step would consist of determining the symptoms caused by the treatment, the extent of the side effects, and particularly the effect of the immunosuppressive treatment on the patient (repeated or severe infections, leukopenia, cancer, etc.).</p></li></ul></p><p id="par0040" class="elsevierStylePara elsevierViewall">These three simple steps could be useful for correctly weighing up the situation of the patient and the effectiveness of the treatment. Nevertheless, the most important factor is indubitably missing from this equation: the opinion of the patient. Another essential step is to discuss the new therapeutic options, and the risks and benefits compared to the previous ones, since, as in life, two heads are generally better than one in coming to the right decision.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Castillo Villegas D, Barril Farré S. Triple terapia en fibrosis pulmonar idiopática. Arch Bronconeumol. 2014;50:260–261.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Normativa sobre el diagnóstico y tratamiento de la fibrosis pulmonar idiopática" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Xaubet" 1 => "J. Ancoechea" 2 => "E. Bollo" 3 => "E. Fernádez-Fabrellas" 4 => "T. Franquet" 5 => "M. Molina-Molina" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.arbres.2013.03.011" "Revista" => array:6 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2013" "volumen" => "49" "paginaInicial" => "343" "paginaFinal" => "353" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23742884" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Idiopathic pulmonary fibrosis clinical research network. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "G. Raghu" 1 => "K.J. Anstrom" 2 => "T.E. King Jr." 3 => "J.A. Lasky" 4 => "F.J. Martinez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1113354" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2012" "volumen" => "366" "paginaInicial" => "1968" "paginaFinal" => "1977" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22607134" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Idiopathic pulmonary fibrosis pathogenesis and novel approaches to immunomodulation: we must not be tyrannized by the PANTHER data" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A.U. Wells" 1 => "W.P. Kelleher" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2013" "volumen" => "187" "paginaInicial" => "677" "paginaFinal" => "679" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23540877" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High-dose acetylcysteine in idiopathic pulmonary fibrosis" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "IFIGENIA Study Group" "etal" => true "autores" => array:6 [ 0 => "M. Demedts" 1 => "J. Behr" 2 => "R. Buhl" 3 => "U. Costabel" 4 => "R. Dekhuijzen" 5 => "H.M. Jansen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa042976" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2005" "volumen" => "353" "paginaInicial" => "2229" "paginaFinal" => "2242" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16306520" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Triple therapy in idiopathic pulmonary fibrosis: an alarming press release" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A.U. Wells" 1 => "J. Behr" 2 => "U. Costabel" 3 => "V. Cottin" 4 => "V. Poletti" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.00009112" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2012" "volumen" => "39" "paginaInicial" => "805" "paginaFinal" => "806" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22467722" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15792129/0000005000000006/v1_201405291004/S1579212914001220/v1_201405291004/en/main.assets" "Apartado" => array:4 [ "identificador" => "14576" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Letters to the editor" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/15792129/0000005000000006/v1_201405291004/S1579212914001220/v1_201405291004/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212914001220?idApp=UINPBA00003Z" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 2 | 3 | 5 |
| 2024 October | 40 | 23 | 63 |
| 2024 September | 47 | 16 | 63 |
| 2024 August | 70 | 47 | 117 |
| 2024 July | 36 | 22 | 58 |
| 2024 June | 60 | 37 | 97 |
| 2024 May | 61 | 31 | 92 |
| 2024 April | 41 | 23 | 64 |
| 2024 March | 42 | 19 | 61 |
| 2024 February | 28 | 20 | 48 |
| 2023 March | 5 | 6 | 11 |
| 2023 February | 30 | 22 | 52 |
| 2023 January | 22 | 29 | 51 |
| 2022 December | 45 | 34 | 79 |
| 2022 November | 30 | 24 | 54 |
| 2022 October | 39 | 34 | 73 |
| 2022 September | 30 | 19 | 49 |
| 2022 August | 25 | 35 | 60 |
| 2022 July | 29 | 34 | 63 |
| 2022 June | 25 | 41 | 66 |
| 2022 May | 28 | 43 | 71 |
| 2022 April | 40 | 24 | 64 |
| 2022 March | 49 | 39 | 88 |
| 2022 February | 23 | 36 | 59 |
| 2022 January | 30 | 35 | 65 |
| 2021 December | 21 | 38 | 59 |
| 2021 November | 22 | 42 | 64 |
| 2021 October | 43 | 46 | 89 |
| 2021 September | 19 | 39 | 58 |
| 2021 August | 21 | 37 | 58 |
| 2021 July | 20 | 32 | 52 |
| 2021 June | 41 | 35 | 76 |
| 2021 May | 22 | 38 | 60 |
| 2021 April | 54 | 88 | 142 |
| 2021 March | 35 | 30 | 65 |
| 2021 February | 26 | 23 | 49 |
| 2021 January | 20 | 22 | 42 |
| 2020 December | 22 | 17 | 39 |
| 2020 November | 23 | 9 | 32 |
| 2020 October | 28 | 15 | 43 |
| 2020 September | 18 | 11 | 29 |
| 2020 August | 28 | 20 | 48 |
| 2020 July | 24 | 28 | 52 |
| 2020 June | 15 | 12 | 27 |
| 2020 May | 24 | 8 | 32 |
| 2020 April | 30 | 22 | 52 |
| 2020 March | 21 | 14 | 35 |
| 2020 February | 37 | 16 | 53 |
| 2020 January | 26 | 14 | 40 |
| 2019 December | 27 | 16 | 43 |
| 2019 November | 33 | 19 | 52 |
| 2019 October | 19 | 6 | 25 |
| 2019 September | 15 | 11 | 26 |
| 2019 August | 16 | 7 | 23 |
| 2019 July | 18 | 11 | 29 |
| 2019 June | 18 | 5 | 23 |
| 2019 May | 30 | 7 | 37 |
| 2019 April | 26 | 14 | 40 |
| 2019 March | 32 | 9 | 41 |
| 2019 February | 19 | 17 | 36 |
| 2019 January | 23 | 26 | 49 |
| 2018 December | 27 | 12 | 39 |
| 2018 November | 51 | 28 | 79 |
| 2018 October | 77 | 37 | 114 |
| 2018 September | 24 | 7 | 31 |
| 2018 May | 31 | 1 | 32 |
| 2018 April | 26 | 3 | 29 |
| 2018 March | 27 | 4 | 31 |
| 2018 February | 38 | 6 | 44 |
| 2018 January | 89 | 8 | 97 |
| 2017 December | 94 | 5 | 99 |
| 2017 November | 29 | 7 | 36 |
| 2017 October | 20 | 8 | 28 |
| 2017 September | 28 | 10 | 38 |
| 2017 August | 44 | 9 | 53 |
| 2017 July | 36 | 7 | 43 |
| 2017 June | 50 | 10 | 60 |
| 2017 May | 47 | 9 | 56 |
| 2017 April | 31 | 3 | 34 |
| 2017 March | 29 | 13 | 42 |
| 2017 February | 22 | 7 | 29 |
| 2017 January | 13 | 4 | 17 |
| 2016 December | 27 | 4 | 31 |
| 2016 November | 37 | 8 | 45 |
| 2016 October | 39 | 16 | 55 |
| 2016 September | 32 | 15 | 47 |
| 2016 August | 48 | 10 | 58 |
| 2016 July | 18 | 7 | 25 |
| 2016 March | 2 | 0 | 2 |
| 2016 February | 1 | 0 | 1 |
| 2015 December | 2 | 0 | 2 |
| 2015 October | 38 | 3 | 41 |
| 2015 September | 31 | 7 | 38 |
| 2015 August | 28 | 8 | 36 |
| 2015 July | 31 | 5 | 36 |
| 2015 June | 30 | 6 | 36 |
| 2015 May | 39 | 7 | 46 |
| 2015 April | 27 | 9 | 36 |
| 2015 March | 32 | 4 | 36 |
| 2015 February | 23 | 5 | 28 |
| 2015 January | 34 | 8 | 42 |
| 2014 December | 29 | 8 | 37 |
| 2014 November | 26 | 7 | 33 |
| 2014 October | 44 | 9 | 53 |
| 2014 September | 24 | 14 | 38 |
| 2014 July | 1 | 1 | 2 |
| 2014 June | 0 | 1 | 1 |
Show all
